Posttherapeutic 131I SPECT-CT offers high diagnostic accuracy when the findings on conventional planar imaging are inconclusive and allows a tailored patient treatment regimen
- 24 January 2009
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 36 (6) , 886-893
Abstract
The purpose of this prospective study was to determine the diagnostic impact and influence on patient treatment of posttherapeutic 131I SPECT-CT when the findings on planar posttherapeutic whole-body scintigraphy (ptWBS) were inconclusive.Keywords
This publication has 29 references indexed in Scilit:
- Unusual Intratracheal Metastasis of Differentiated Thyroid Cancer Accurately Depicted by SPECT/CT Acquisition after Radioiodine AblationThyroid®, 2007
- Single-Photon Emission Computed Tomography/Computed Tomography in EndocrinologySeminars in Nuclear Medicine, 2006
- Respective Roles of Thyroglobulin, Radioiodine Imaging, and Positron Emission Tomography in the Assessment of Thyroid CancerSeminars in Nuclear Medicine, 2006
- European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epitheliumEuropean Journal of Endocrinology, 2006
- Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus reportEuropean Journal of Endocrinology, 2005
- Are Posttherapy Radioiodine Scans Informative and Do They Influence Subsequent Therapy of Patients with Differentiated Thyroid Cancer?Thyroid®, 2000
- False-positive I-131 Whole-body Imaging After I-131 Therapy for a Follicular CarcinomaClinical Nuclear Medicine, 1997
- Prognostic factors and risk group analysis in follicular carcinoma of the thyroidSurgery, 1995
- False-Positive Radioiodine Whole-Body Scan in Thyroid Cancer Patients Due to Unrelated PathologyClinical Nuclear Medicine, 1994
- A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. thyroid cancer cooperative group1979